Literature DB >> 353655

[Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)].

C Mazurier, A Parquet-Gernez, M Goudemand.   

Abstract

Factor VIII-related antigen is measured by ELISA as follows: Factor VIII-R: Ag is first "captured" between rabbit antibodies to human factor VII R : Ag adsorbed in polystyrene tubes, and conjugate (peroxydase-labelled rabbit antibodies). A chromogenic enzyme substrate is then added and absorbence measurement allows subsequent assay. This method is sensitive, reproducible and specific. The comparison between the results obtained by this enzyme immuno-assay and the electro-immunodiffusion assay (EIA) is interesting for the study of quantitative and qualitative variations of F VII R : Ag in von Willebrand's disease. Two observations of von Willerbrand variants are described in detail : VIII R : Ag plasma level of the first one is normal using EIA but decreased using ELISA, its electrophoretic mobility is increased; in the second case we found typical anomalies of von Willebrand except the VIII R : Ag level normal by the two methods.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 353655

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

1.  Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.

Authors:  R Schneppenheim; J Brassard; S Krey; U Budde; T J Kunicki; L Holmberg; J Ware; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

2.  Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.

Authors:  T Obser; M Ledford-Kraemer; F Oyen; M A Brehm; C V Denis; R Marschalek; R R Montgomery; J E Sadler; S Schneppenheim; U Budde; R Schneppenheim
Journal:  J Thromb Haemost       Date:  2016-08-20       Impact factor: 5.824

3.  Genetic heterogeneity of severe von Willebrand disease type III in the German population.

Authors:  R Schneppenheim; S Krey; F Bergmann; D Bock; U Budde; M Lange; R Linde; U Mittler; E Meili; G Mertes
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

4.  Identification of a candidate missense mutation in a family with von Willebrand disease type IIC.

Authors:  R Schneppenheim; K B Thomas; S Krey; U Budde; U Jessat; A H Sutor; B Zieger
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

5.  Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia.

Authors:  C Mühlhausen; R Schneppenheim; U Budde; M Merkel; N Muschol; K Ullrich; R Santer
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.